Clorox (CLX) PT Lowered to $110 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $97.12 +3.54%
Rating Summary:
1 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Rating Summary:
1 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Join SI Premium – FREE
Morgan Stanley analyst Dara Mohsenian lowered the price target on Clorox (NYSE: CLX) to $110.00 (from $136.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Clorox (CLX) PT Raised to $94 at Morgan Stanley
- Clorox (CLX) PT Raised to $88 at TD Cowen
- Boise Cascade Company (BCC) PT Lowered to $85 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
